204 related articles for article (PubMed ID: 6626452)
41. Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70.
Wei Y; Zhao X; Kariya Y; Fukata H; Teshigawara K; Uchida A
Cancer Res; 1996 Mar; 56(5):1104-10. PubMed ID: 8640768
[TBL] [Abstract][Full Text] [Related]
42. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.
Timonen T; Ortaldo JR; Herberman RB
J Exp Med; 1981 Mar; 153(3):569-82. PubMed ID: 6166701
[TBL] [Abstract][Full Text] [Related]
43. The concurrent administration of OK432 augments the antitumor vaccination effect with tumor cells by sustaining locally infiltrating natural killer cells.
Kurosawa S; Harada M; Shinomiya Y; Terao H; Nomoto K
Cancer Immunol Immunother; 1996 Sep; 43(1):31-8. PubMed ID: 8917633
[TBL] [Abstract][Full Text] [Related]
44. Natural cytotoxicity of lymphocytes and monocytes and its augmentation by OK432 in melanoma patients.
Yanagawa E; Uchida A; Kokoschka EM; Micksche M
Cancer Immunol Immunother; 1984; 16(3):131-6. PubMed ID: 6200209
[TBL] [Abstract][Full Text] [Related]
45. Factors determining the ability of cytokine-activated killer cells to lyse human ovarian carcinoma targets.
Hirte HW; Clark DA
Cell Immunol; 1991 Aug; 136(1):122-32. PubMed ID: 2060017
[TBL] [Abstract][Full Text] [Related]
46. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
Mandler RN; Biddison WE; Mandler R; Serrate SA
J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
[TBL] [Abstract][Full Text] [Related]
47. Differential effects of beta- and gamma-interferons on natural killer cell-mediated lysis of lung carcinoma cells.
Krishnamurti C; Ahrens P; Ankel H
Immunobiology; 1987 Mar; 174(2):221-32. PubMed ID: 3110053
[TBL] [Abstract][Full Text] [Related]
48. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
[TBL] [Abstract][Full Text] [Related]
49. Defective NK cell activity following thermal injury.
Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
[TBL] [Abstract][Full Text] [Related]
50. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190
[TBL] [Abstract][Full Text] [Related]
51. Cell regulatory and immunorestorative activity of picibanil (OK432).
Chirigos MA; Saito T; Talmadge JE; Budzynski W; Gruys E
Cancer Detect Prev Suppl; 1987; 1():317-28. PubMed ID: 3480058
[TBL] [Abstract][Full Text] [Related]
52. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
[TBL] [Abstract][Full Text] [Related]
53. Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors.
Wakasugi H; Oshimi K; Miyata M; Morioka Y
J Clin Immunol; 1981 Jul; 1(3):154-62. PubMed ID: 6174541
[TBL] [Abstract][Full Text] [Related]
54. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
55. Human ovarian carcinoma: evidence for patient-related differences in susceptibility to cytotoxic effectors that attack different cellular subpopulations within a tumour.
Clark DA; Hirte HW; Buick RN
Br J Cancer; 1988 Oct; 58(4):415-8. PubMed ID: 3264715
[TBL] [Abstract][Full Text] [Related]
56. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
57. Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiers.
Nio Y; Zighelboim J; Berek JS; Bonavida B
Anticancer Res; 1990; 10(2A):441-6. PubMed ID: 2346317
[TBL] [Abstract][Full Text] [Related]
58. Suppression of natural killer cell activity by adherent effusion cells of cancer patients. Suppression of motility, binding capacity and lethal hit of NK cells.
Uchida A; Colot M; Micksche M
Br J Cancer; 1984 Jan; 49(1):17-23. PubMed ID: 6691897
[TBL] [Abstract][Full Text] [Related]
59. Lymphocyte activation by recombinant interleukin-2 in ovarian cancer patients.
Boyer PJ; Berek JS; Zighelboim J
Obstet Gynecol; 1989 May; 73(5 Pt 1):793-7. PubMed ID: 2784847
[TBL] [Abstract][Full Text] [Related]
60. Combination of OK432 and human interferon-alpha for treating viral-induced diabetes mellitus in mice.
Kanda T; Kogure S; Nara M; Tsukui S; Utsugi T; Tomono S; Kawazu S; Nagai R; Kobayashi I
Eur J Pharmacol; 1998 Jan; 342(2-3):297-302. PubMed ID: 9548400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
